MedPath

Investigation of the effect of pentoxifylline on the prevention of radio contrast nephropathy

Phase 3
Conditions
Kidney disorders caused by contrast material following angiography.
Registration Number
IRCT20161219031464N4
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
192
Inclusion Criteria

The criteria for entering the study include patients who are candidates for angiography with cardiac service indications and will be admitted to cardiac service.

Exclusion Criteria

patients with stage 5 CKD,
kidney transplantation,
patients with renal insufficiency with a GFR below 30
patients with a history of allergy to pentoxifylline according to history.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum creatinine and creatinine clearance. Timepoint: Serum creatinine and clearance creatinine of patients will be tested the day before and the next day and 48 hours later. Method of measurement: blood and urine sample examination.;C reactive protein. Timepoint: The day before and after angiography. Method of measurement: Blood test.;Proteinuria. Timepoint: The day before and after angiography. Method of measurement: Urine examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath